To know the importance of Homoeopathy in the treatment of Vitiligo
Phase 2
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2022/07/044187
- Lead Sponsor
- ational Institute of Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient diagnosed as Vitiligo to clinical features and having concomitant symptoms.
Patient all socio economic with all religions and all age group
Exclusion Criteria
Patients who are too sick for consultation.
Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life- threatening illness.
Lactating or Pregnant Women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the improvement of the patients using VASI scoring.Timepoint: Baseline,3rd month and 6th month.
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie individualized Homoeopathic medicine efficacy in Vitiligo treatment?
How does individualized Homoeopathy compare to standard-of-care treatments for L80 Vitiligo in clinical outcomes?
Are there specific biomarkers that predict response to Homoeopathic treatment in L80 Vitiligo patients?
What are the known or potential adverse events associated with individualized Homoeopathic medicine for Vitiligo?
What combination approaches or competitor drugs are being explored for L80 Vitiligo treatment alongside Homoeopathy?